# A Study Investigating Lu AG22515 in Healthy Adults

> **NCT05136053** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 58 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Lu AG22515
- **DRUG:** Placebo
- **DRUG:** Immune System Activator

## Key facts

- **NCT ID:** NCT05136053
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-18
- **Primary completion:** 2023-08-05
- **Final completion:** 2023-08-05
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2023-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05136053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05136053, "A Study Investigating Lu AG22515 in Healthy Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05136053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*